TREATMENT OF ANEMIA RESISTANT TO CONVENTIONAL ERYTHROPOIETIN THERAPY WITH THYMOPENTIN IN HEMODIALYSIS-PATIENTS

被引：3
|
作者：
RAIOLA, P [1 ]
MANZO, M [1 ]
SAGGESE, A [1 ]
TOMASINO, G [1 ]
CICCHELLA, T [1 ]
RAMBALDI, M [1 ]
PISANO, M [1 ]
LIZZA, B [1 ]
PERNA, AF [1 ]
机构：
[1] UNIV NAPLES 2,SCH MED,DEPT PEDIAT,CHAIR NEPHROL,NAPLES,ITALY
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 1995年 / 10卷
关键词：
CHRONIC RENAL FAILURE; RESISTANT ANEMIA; ERYTHROPOIETIN; THYMOPENTIN;
D O I：
10.1093/ndt/10.supp6.48
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：48 / 50
页数：3
相关论文
共 50 条
  • [41] Evaluation of the Effect of Pentoxifylline on Erythropoietin-resistant Anemia in Hemodialysis Patients
    Mohammadpour, Amir-Hooshang
    Nazemian, Fatemeh
    Khaiat, Mohammad Hassanzade
    Tafaghodi, Mohsen
    Salari, Pooneh
    Charkazi, Somaieh
    Naghibi, Masih
    Shamsara, Jamal
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2014, 25 (01) : 73 - 78
  • [42] INDICATIONS AND CONTRAINDICATIONS FOR RECOMBINANT HUMAN ERYTHROPOIETIN TREATMENT - RESULTS IN HEMODIALYSIS-PATIENTS
    SAMTLEBEN, W
    BALDAMUS, CA
    BOMMER, J
    GRUTZMACHER, P
    NONNASTDANIEL, B
    SCIGALLA, P
    GURLAND, HJ
    ERYTHROPOIETIN : FROM MOLECULAR STRUCTURE TO CLINICAL APPLICATION, 1989, 76 : 193 - 200
  • [43] REVERSAL OF GLUCOSE-INTOLERANCE AND INSULIN RESISTANCE FOLLOWING CORRECTION OF ANEMIA BY HUMAN RECOMBINANT ERYTHROPOIETIN THERAPY IN HEMODIALYSIS-PATIENTS
    MAK, RHK
    CLINICAL RESEARCH, 1992, 40 (02): : A354 - A354
  • [44] USE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN (RH-EPO) IN THE TREATMENT OF ANEMIA IN HEMODIALYSIS-PATIENTS - A MULTICENTER ITALIAN EXPERIENCE
    BUCCIANTI, G
    COLOMBI, L
    BATTISTEL, V
    HAEMATOLOGICA, 1993, 78 (02) : 111 - 117
  • [45] REACTIVITY OF PATIENTS WITH MAINTENANCE HEMODIALYSIS TO ERYTHROPOIETIN IN THE TREATMENT OF RENAL ANEMIA
    Hu, J. P.
    Cheng, X.
    Xu, X. F.
    Yu, G. J.
    Luo, F.
    Zhang, G. S.
    Yang, N.
    Shen, P.
    Yan, X. Y.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2016, 30 (02): : 535 - 540
  • [46] Improvement of anemia and secondary hyperparathyroidism with erythropoietin treatment in hemodialysis patients
    Seyrek, N
    Paydas, S
    Sagliker, Y
    NEPHRON, 1996, 73 (02): : 338 - 339
  • [47] EFFECT OF ERYTHROPOIETIN THERAPY AND WITHDRAWAL ON BLOOD-COAGULATION AND FIBRINOLYSIS IN HEMODIALYSIS-PATIENTS
    TAYLOR, JE
    BELCH, JJF
    MCLAREN, M
    HENDERSON, IS
    STEWART, WK
    KIDNEY INTERNATIONAL, 1993, 44 (01) : 182 - 190
  • [48] ATP PRODUCTION IN ISOLATED MUSCLE MITOCHONDRIA FROM HEMODIALYSIS-PATIENTS - EFFECTS OF CORRECTION OF ANEMIA WITH ERYTHROPOIETIN
    BARANY, P
    WIBOM, R
    HULTMAN, E
    BERGSTROM, J
    CLINICAL SCIENCE, 1991, 81 (05) : 645 - 653
  • [49] LONG-TERM EFFECTS ON QUALITY-OF-LIFE IN HEMODIALYSIS-PATIENTS OF CORRECTION OF ANEMIA WITH ERYTHROPOIETIN
    BARANY, P
    PETTERSSON, E
    KONARSKISVENSSON, JK
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1993, 8 (05) : 426 - 432
  • [50] THE HEMODYNAMIC-EFFECTS OF CORRECTION OF ANEMIA IN HEMODIALYSIS-PATIENTS USING RECOMBINANT-HUMAN-ERYTHROPOIETIN
    ABDULHADI, MH
    FOUADTARAZI, FM
    THOMAS, T
    BRAVO, EL
    PAGANINI, EP
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1990, 5 : 102 - 108
12345